{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:46:16Z","timestamp":1754599576515},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.contraception.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T07:38:58Z","timestamp":1542008338000},"page":"125-130","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17\u03b2-estradiol in the treatment of women with primary dysmenorrhea"],"prefix":"10.1016","volume":"99","author":[{"given":"Michelle C.","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Klipping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison Martin","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara L.","family":"Frenkl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra M.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinna","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjeerd","family":"Korver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2018.10.009_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.contraception.2009.09.014","article-title":"Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review","volume":"81","author":"Zahradnik","year":"2010","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2018.10.009_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","article-title":"Primary Dysmenorrhea; Advances in pathogenesis and management","volume":"108","author":"Dawood","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.10.009_bb0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.332.7550.1134","article-title":"Diagnosis and management of dysmenorrhea","volume":"332","author":"Proctor","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2018.10.009_bb0020","first-page":"1","article-title":"Oral contraceptive pill for primary dysmenorrhoea (review)","volume":"4","author":"Wong","year":"2009","journal-title":"Cochrane Collab"},{"key":"10.1016\/j.contraception.2018.10.009_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/13625180701440180","article-title":"Clinical experience with NuvaRing\u00ae in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages","volume":"12","author":"Merki-Feld","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.10.009_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13625180701577122","article-title":"Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing\u00ae: results of clinical experience in Germany","volume":"13","author":"Brucker","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.10.009_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000298338.58511.d1","article-title":"Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial","volume":"111","author":"Creinin","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.contraception.2018.10.009_bb0040","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/humrep\/del162","article-title":"Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 micrograms ethinyl estradiol and 3 mg drospirenone","volume":"21","author":"Milsom","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2018.10.009_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/13625187.2012.713535","article-title":"The contraceptive vaginal ring, NuvaRing, a decade after its introduction","volume":"17","author":"Roumen","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.10.009_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0010-7824(02)00414-6","article-title":"Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive","volume":"66","author":"Hendrix","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.10.009_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.AOG.0000165826.03915.65","article-title":"Oral contraceptives for dysmenorrhea in adolescent girls; a randomized trial","volume":"106","author":"Davis","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.10.009_bb0060","first-page":"1","article-title":"Mood changes and menstrual symptoms with different gestagen\/estrogen combinations. A double blind comparison with a placebo","volume":"236","author":"Cullberg","year":"1972","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.contraception.2018.10.009_bb0065","series-title":"Menstrual distress questionnaire manual, instrument and scoring guide","author":"Moos","year":"2010"},{"key":"10.1016\/j.contraception.2018.10.009_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11136-014-0755-z","article-title":"A qualitative study to develop a patient-reported outcome for dysmenorrhea","volume":"24","author":"Nguyen","year":"2015","journal-title":"Qual Life Res"},{"key":"10.1016\/j.contraception.2018.10.009_bb0075","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s11136-017-1562-0","article-title":"Psychometric validation of the dysmenorrhea daily diary (DysDD): a patient-reported outcome for dysmenorrhea","volume":"26","author":"Nguyen","year":"2017","journal-title":"Qual Life Res"},{"issue":"Series B, Pt. 1","key":"10.1016\/j.contraception.2018.10.009_bb0080","first-page":"134","article-title":"Longitudinal data analysis of continuous and discrete responses for pre-post designs","volume":"62","author":"Liang","year":"2000","journal-title":"Sankhya Indian J Stat"},{"issue":"272","key":"10.1016\/j.contraception.2018.10.009_bb0085","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"A multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.contraception.2018.10.009_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002120.pub2","article-title":"Oral contraceptive pill for primary dysmenorrhoea","volume":"4","author":"Wong","year":"2009","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418304815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418304815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T23:10:40Z","timestamp":1548457840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782418304815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0010782418304815"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2018.10.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17\u03b2-estradiol in the treatment of women with primary dysmenorrhea","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}